567 related articles for article (PubMed ID: 33493641)
1. Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines.
Murphy KR; Patel NC; Ein D; Hudelson M; Kodoth S; Marshall GD; Parikh P; Blaiss MS
Ann Allergy Asthma Immunol; 2021 Apr; 126(4):319-320. PubMed ID: 33493641
[No Abstract] [Full Text] [Related]
2. Allergic Reactions to COVID-19 Vaccines: An Allergist's Perspective.
Cruz C; Gaspar Â; Borrego LM
Acta Med Port; 2021 Mar; 34(3):243. PubMed ID: 33547771
[No Abstract] [Full Text] [Related]
3. Polyethylene glycol and polysorbate skin testing in the evaluation of coronavirus disease 2019 vaccine reactions: Early report.
Pitlick MM; Sitek AN; Kinate SA; Joshi AY; Park MA
Ann Allergy Asthma Immunol; 2021 Jun; 126(6):735-738. PubMed ID: 33775902
[No Abstract] [Full Text] [Related]
4. Anaphylaxis associated with the mRNA COVID-19 vaccines: Approach to allergy investigation.
Erdeljic Turk V
Clin Immunol; 2021 Jun; 227():108748. PubMed ID: 33932618
[TBL] [Abstract][Full Text] [Related]
5. The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy.
Ortega Rodríguez NR; Audícana Berasategui MT; de la Hoz Caballer B; Valero Santiago A
J Investig Allergol Clin Immunol; 2021 Feb; 31(1):89-91. PubMed ID: 33393485
[No Abstract] [Full Text] [Related]
6. Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients.
Rojas-Pérez-Ezquerra P; Crespo Quirós J; Tornero Molina P; Baeza Ochoa de Ocáriz ML; Zubeldia Ortuño JM
J Investig Allergol Clin Immunol; 2021 Apr; 31(2):180-181. PubMed ID: 33648905
[No Abstract] [Full Text] [Related]
7. Vaccinating against covid-19 in people who report allergies.
Glover RE; Urquhart R; Lukawska J; Blumenthal KG
BMJ; 2021 Jan; 372():n120. PubMed ID: 33461962
[No Abstract] [Full Text] [Related]
8. [Allergic reactions to COVID-19 vaccines].
Geersing TH; Tempels-Pavlica Ž; Borgsteede SD
Ned Tijdschr Geneeskd; 2021 Feb; 165():. PubMed ID: 33651507
[TBL] [Abstract][Full Text] [Related]
9. Specialist allergy advice allows vaccination in patients with reactions to COVID-19 vaccines.
Harper V; Gurugama P; Ewan P; Nasser S; Sellaturay P
Clin Exp Allergy; 2022 Mar; 52(3):465-469. PubMed ID: 34854156
[No Abstract] [Full Text] [Related]
10. COVID vaccines and safety: what the research says.
Remmel A
Nature; 2021 Feb; 590(7847):538-540. PubMed ID: 33597779
[No Abstract] [Full Text] [Related]
11. COVID-19 Vaccines in Children with Cow's Milk and Food Allergies.
Liotti L; Bianchi A; Bottau P; Caimmi S; Crisafulli G; Franceschini F; Mori F; Paglialunga C; Saretta F; Caffarelli C
Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444795
[TBL] [Abstract][Full Text] [Related]
12. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines.
Moghimi SM
Mol Ther; 2021 Mar; 29(3):898-900. PubMed ID: 33571463
[No Abstract] [Full Text] [Related]
13. Basophil reactivity to BNT162b2 is mediated by PEGylated lipid nanoparticles in patients with PEG allergy.
Troelnikov A; Perkins G; Yuson C; Ahamdie A; Balouch S; Hurtado PR; Hissaria P
J Allergy Clin Immunol; 2021 Jul; 148(1):91-95. PubMed ID: 33991580
[TBL] [Abstract][Full Text] [Related]
14. Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines.
Risma KA; Edwards KM; Hummell DS; Little FF; Norton AE; Stallings A; Wood RA; Milner JD
J Allergy Clin Immunol; 2021 Jun; 147(6):2075-2082.e2. PubMed ID: 33857566
[TBL] [Abstract][Full Text] [Related]
15. Safe Administration of SARS-CoV-2 Vaccine After Desensitization to a Biologic Containing Polysorbate 80 in a Patient With Polyethylene Glycol-Induced Severe Anaphylaxis and Sensitization to Polysorbate 80.
Nin-Valencia A; Fiandor A; Lluch M; Quirce S; Caballero T; Heredia Revuelto R; González-Muñoz M; Caballero ML; Cabañas R
J Investig Allergol Clin Immunol; 2023 Apr; 33(2):151-153. PubMed ID: 35638393
[No Abstract] [Full Text] [Related]
16. Clinical manifestations and impact on daily life of allergy to polyethylene glycol (PEG) in ten patients.
Bruusgaard-Mouritsen MA; Johansen JD; Garvey LH
Clin Exp Allergy; 2021 Mar; 51(3):463-470. PubMed ID: 33394522
[TBL] [Abstract][Full Text] [Related]
17. mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.
Rama TA; Moreira A; Castells M
J Allergy Clin Immunol; 2021 Mar; 147(3):877-878. PubMed ID: 33485650
[No Abstract] [Full Text] [Related]
18. Risk of allergic reaction in patients with atopic disease and recent coronavirus disease 2019 vaccination.
Dages KN; Pitlick MM; Joshi AY; Park MA
Ann Allergy Asthma Immunol; 2021 Aug; 127(2):257-258. PubMed ID: 33962029
[No Abstract] [Full Text] [Related]
19. Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine - United States, December 21, 2020-January 10, 2021.
Shimabukuro T
Am J Transplant; 2021 Mar; 21(3):1326-1331. PubMed ID: 33641268
[No Abstract] [Full Text] [Related]
20. COVID-19 vaccination: Recommendations for management of patients with allergy or immune-based diseases.
Peter J
S Afr Med J; 2021 Feb; 111(4):291-294. PubMed ID: 33944757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
